Skip to main content
. 2018 May 30;16(2):529–536. doi: 10.3892/etm.2018.6235

Figure 4.

Figure 4.

Effect of anti-TNF-α treatment on the expression of the pro-inflammatory cytokines TNF-α, IL-1β, IL-6 and IL-17 in a hepatocellular carcinoma xenograft mouse model. The levels of (A) TNF-α, (B) IL-1β, (C) IL-6 and D (IL-17) were evaluated by ELISA. TNF-α treatment promoted the expression of these cytokines, but infliximab reversed these effects. TNF-α, tumor necrosis factor-α; IL, interleukin; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.